Lidocaine Hci 3.88%

Prescription

상품명: Bruselix Gel

제형

Topical

투여 경로

TOPICAL

제조사

PureTek Corporation

About This Medication

DESCRIPTION: Bruselix™ Gel contains 38.8 mg of Lidocaine HCI per gram in a mild acidic vehicle with Aloe Barbadensis (Aloe Vera) Leaf Juice, Aqua (Purified Water), Arnica Montana (Arnica) Flower Extract, Citric Acid, Ethylhexylglycerin, Glycerin, Hydroxyethylcellulose, PEG-4, Phenoxyethanol, Potassium Sorbate, Propylene Glycol, Sodium Benzoate. Lidocaine HCl is chemically designated as acetamide, 2-(diethylamino)-N-(2,6 dimethylphenyl), and has the following structure: Label

유효 성분

성분	함량
Lidocaine Hydrochloride	-

적응증 및 용법

INDICATIONS: For the temporary relief of pain.

용량 및 투여 방법

DOSAGE: Apply a thin film to the affected area two or three times daily or as directed by a licensed healthcare practitioner.

Side Effects Overview

ADVERSE REACTIONS: During or immediately after treatment, the skin at the site of treatment may develop erythema or edema or may be the locus of abnormal sensation.

경고 및 주의 사항

WARNINGS: For external use only. Not for ophthalmic use.

금기

CONTRAINDICATIONS: Tuberculous or fungal lesions of skin vaccinia, varicella and acute herpes simplex and in persons who have shown hypersensitivity to any of its components. Lidocaine is contraindicated in patients with a known history of hypersensitivity to local anesthetics of the amide type.

Frequently Asked Questions

INDICATIONS: For the temporary relief of pain.

DOSAGE: Apply a thin film to the affected area two or three times daily or as directed by a licensed healthcare practitioner.

WARNINGS: For external use only. Not for ophthalmic use.

CONTRAINDICATIONS: Tuberculous or fungal lesions of skin vaccinia, varicella and acute herpes simplex and in persons who have shown hypersensitivity to any of its components. Lidocaine is contraindicated in patients with a known history of hypersensitivity to local anesthetics of the amide type.

Lidocaine Hci 3.88% is a prescription medication. You will need a valid prescription from a licensed healthcare provider.

References & Data Sources

• DailyMed — Lidocaine Hci 3.88% drug label (National Library of Medicine)
• openFDA — Lidocaine Hci 3.88% label data (U.S. Food & Drug Administration)
• RxNorm — RXCUI 2675768 (NLM Normalized Drug Names)
• NDC Directory — Lidocaine Hci 3.88% (FDA National Drug Code)

의료 면책 조항

이 페이지의 정보는 교육 목적으로만 제공되며, 전문적인 의학적 조언, 진단 또는 치료를 대체하는 용도로 사용해서는 안 됩니다.

의학적 상태나 의약품에 관한 질문이 있으시면 반드시 의사 또는 자격을 갖춘 의료 전문가에게 조언을 구하시기 바랍니다.

데이터 출처: DailyMed (NLM), openFDA, MFDS